Becas Gilead a la investigación biomédica
Proyectos seleccionados
9ª Convocatoria de Becas Gilead a la Investigación Biomédica en VIH, COVID-19, Hepatitis Virales C y Delta, Infección Fúngica Invasora, Linfomas de estirpe B y Oncología Médica.COVID:
Xavier Solanich Moreno
Neutralizing autoantibodies against type I interferons continue to confer a higher risk of severe COVID-19 in fully vaccinated population?
Instituto De Investigación Biomédica De Bellvitge (Idibell)
Carlos Luis Parra Calderón
FLANDERS: Fast LeArniNg coviD 19 carE System
Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla
VIH:
Maria Jose Buzón Gomez
Identification of HIV-latency markers in human tissues
Fundación Instituto De Investigación Valle De Hebrón
Jose Ramon Blanco Ramos
loneliness and/or social isolation in persons living with hiv over 50 years old. Biomarkers signatures. Substudy
Fundación Seimc/Gesida
Norma Ibón Rallón Afanador
Exosomes as triggers of non-AIDS-defining cancers development in the context of HIV pathogenesis
Fundación Instituto De Investigación Sanitaria Fundación Jimenez Diaz
Cesar Fernandez Sanchez
Development of pioneering quantitative molecular diagnostic assays based on an innovative aptamer nanotechnological approach for high-throughput and point-of-care early diagnosis of HIV
Instituto Ramon Y Cajal De Investigación Sanitaria (Irycis)
Maria Pernas Escario
Determination of factors associated with protection against Human Immunodeficiency VIrus type 1 Reinfection: Identification of protection correlates.
Instituto De Salud Carlos Iii, O.A., M.P
David Dalmau Juanola
Monocytes imprints as predictors of cardiovascular risk in PLWH
Fundación Mutua De Terrassa
Ezequiel Ruiz-Mateos Carmona
Analysis of the quality of HIV-1 reservoir in persistent elite controllers and people on long-term cART, association with immune parameters.
Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla
Hepatitis:
Manuel Romero Gomez
Pre-HepC: Predictor of hepatitis C in undiagnosed patients based on real-world evidence
Fundación Pública Andaluza Para La Gestion De La Investigación En Salud De Sevilla
Francisco Rodriguez Frías
Standard-HDV. Standardization of HDV-RNA quantification: a need that can no longer be ignored
Fundación Instituto De Investigación Valle De Hebrón
Hemato-Oncología/ Linfoma:
Mariana Bastos Oreiro
Dynamics of circulating tumor DNA and other biomarkers prior to infusion of CAR-T therapy as a prognostic marker of treatment failure in diffuse large B cell lymphoma
Fundación Investigación Biomédica Hospital Gregorio Marañón
Ana Fernandez Cruz
A prospective multicenter study to determine the usefulness of systematic 18-FDG-PET-TC for the management of invasive fungal infection (PETIFI project)
Hospital Puerta De Hierro
Pedro Puerta Alcalde
Real-life invasive fungal disease epidemiology in a tertiary center in Spain: new hosts and changing epidemiology
Fundacio Clinic Per A La Recerca Biomédica
Teresa Caballero Velázquez
Prediction of car-t cell treatment response: searching for biomarkers
Instituto De Biomedicina De Sevilla - Ibis
Oncología Médica:
Albert Font Pous
Comprehensive analysis of urine biomarkers to predict pathologic complete response in muscle-invasive bladder cancer patients treated with neoadjuvant therapy
Fundación Instituto Inv Germans Trias I Pujol
Beatriz Castelo Fernandez
Identification of new biomarkers to predict patient progression in ductal salivary cancer
Fundación Investigación Biomédica Hospital La Paz
Juan Miguel Cejalvo Andujar
The role of AXL in modulating tumor microenvironment as potential therapeutic strategy for HER2- positive breast cancer
Instituto De Investigación Sanitaria Incliva
Noelia Martinez Jañez
Male Breast Cancer: molecular characterization for personalized clinical management of a rare disease
Fundación Grupo Español Investigación En Cancer De Mama (Geicam)
Tania Carolina Fleitas Kanonnikoff
Prognostic and predictive impact of the microbiome and the tumor immune microenvironment on advanced gastric cancer across young patients (minors 50 YO): VERO-2 project.
Instituto De Investigación Sanitaria Incliva
Luis Manuel Manso Sanchez
Deep Learning and morphological patterns of Homologous Recombination Deficiency in ovarian cancers from whole slide images
Fundación Investigación Biomédica Hospital 12 De octubre